Skip to Content
MilliporeSigma
Search Within
Document Type

577-11-7

Applied Filters:
Keyword:'577-11-7'
Showing 1-30 of 107 results for "577-11-7" within Technical Documents
Data Sheet - F8926
Tyrosine 576 and 577, located in the activation loop of the kinase domain of FAK, are also phosphorylated by Src. FAK’s catalytic activity may be increased by phosphorylation of these residues.7 While phosphorylation
Product Information Sheet - M9281
Hendil, K.B. et al., Biochem. J., 272(3), 577-581 (1990). 7. Susan, P.P., and Dunn, W.A., Jr., J. Cell. Physiol., 187(1), 48-58 (2001). 8. Knöferle, J., Koch, J.C. et al., Proc. Nat. Acad. Sci
Product Information Sheet - G3126
4479. 3. Biochemistry, 3rd ed., Stryer, L., W. H. Freeman (New York, NY: 1988), pp. 20, 505, 577, 579. 4. Textbook of Biochemistry with Clinical Correlations, 5th ed., Devlin, T. M., ed., Wiley-Liss
Data Sheet - H9163
developed in rabbit using as immunogen a synthetic peptide corresponding to amino acid residues 577-590 of human HDRP/MITR with N-terminal added cysteine, conjugated to KLH. The corresponding
Data Sheet - F9426
Tyrosine 576 and 577, located in the activation loop of the kinase domain of FAK, are also phosphorylated by Src. FAK’s catalytic activity may be increased by phosphorylation of these residues.7 While
TB051VM pET-23a-d(+) Vector Map
2641 3415 Enzyme # Sites Locations Sau3AI 19 ScaI 1 2761 ScrFI 11 SfaNI 13 SfcI 5 302 1653 1844 2522 3643 SspI 2 3085 3216 StyI 1 57 TaqI 7 159 180 190 331 1488 2932 3457 TaqII 6 1290 2629 2814 2967
Data Sheet - F7926
Tyrosine 576 and 577, located in the activation loop of the kinase domain of FAK, are also phosphorylated by Src. FAK’s catalytic activity may be increased by phosphorylation of these residues.7 While phosphorylation
Data Sheet - F8801
binding site and provides a link to the activation of the Ras signal transduction pathway.7 Tyrosine 576 and 577, located in the activation loop of the kinase domain of FAK, are also phosphorylated by
Data Sheet - I17003
., Inhibition of human macrophage colony formation by interleukin 4. J. Exp. Med., 170, 577-582 (1989). 7. Rosenzwajg, M., et al., The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human
Data Sheet - I3653
Gen. Virol., 35, 573-577 (1977). 5. Rosenblum, M.G. et al., J. Interferon Res., 10, 141- 151 (1990). 6. Belhumeur, P. et al., Mol. Cell. Biol., 13, 2846-2857 (1993). 7. Pfeffer, L. M., and Constantinescu
TB217 pBAC™-3 Vector Map
3778 3789 3875 3887 4655 4672 Cac8I 24 ClaI 2 2613 2936 CviJI 64 DdeI 7 564 1554 2495 3412 3821 3987 4527 DpnI 23 DraI 7 45 577 1731 3017 3896 3915 4607 DraIII 1 5182 DrdI 2 3245 5226 Enzyme #
Data Sheet - P4334 - Lot 085H4848
697), PKC (662-673), PKC � (726-737), or PKC � (30kDa) and a fragment containing the C-terminal (577-592). kinase domain (50kDa) which is catalytically active. Protein Concentration: 59.6 mg/ml by
Product Information Sheet - IMMH7
immunofluorescent technique, J. Histotechnology, 3, 10 (1980). IMMH-7.p65 8/22/2005, 4:08 PM10 11 NOTES IMMH-7.p65 8/22/2005, 4:08 PM11 Sigma brand products are sold through
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
TB133 pBAC4x-1 Vector Map
4970 DpnI 30 DraI 7 45 577 2174 3460 4339 4358 5050 DraIII 1 5625 DrdI 2 3688 5669 DrdII 1 5617 EaeI 2 1953 4861 EagI 1 1953 Eam1105I 2 647 4473 EarI 4 199 695 5268 5906 EciI 7 11 2811 2817 2823 3654
TB162VM pET-30 Ek/LIC Vector Map
2121 2209 2300 2579 BamHI 1 198 BanI 10 251 327 515 536 650 1113 1832 1962 2088 5234 BanII 7 190 235 577 591 1404 4151 5272 BbsI 4 1339 1678 2052 2412 BbvI 25 BccI 14 Bce83I 6 21 2007 2177 3385 3683
TB127 pBAC-1 Vector Map
4457 Cac8I 23 CjeI 20 CjePI 12 ClaI 2 2398 2721 CviJI 61 CviRI 15 DdeI 7 564 1339 2280 3197 3606 3772 4312 DpnI 23 DraI 7 45 577 1516 2802 3681 3700 4392 DraIII 1 4967 DrdI 2 3030 5011 DrdII 1 4959
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
In Vitro Toxicology Kits
Screening of Synthetic and Natural Products for AIDS-Antiviral Activity. J. Natl. Cancer Inst., 81: 577-586. 9. Roehm, N. et al. (1991). An Improved Colorimetric Assay for Cell Proliferation and Viability
Product Information Sheet - IMMH6
techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577 (1981). 5. Tacos, N.A., et al., Immunocytochemical study of the glial fibrillary acidic protein
Data Sheet - E1523
and loop-12 domain, which includes two proline-rich regions. The proline-rich region (amino acids 577-699) contains several small Pro-Ala repeats (PA) 3, followed by Pro-Thr repeats (PT) 3. Also, the
Product Information Sheet - IMMH9
techniques: A comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577 (1981). 5. Nakajima, T., et al., S-100 Protein Distribution in Normal and Neoplastic Tissues, in
Data Sheet - F9176
focal adhesions and requirement for the autophosphorylation site., Cell Growth Differ., 11, 41-48 (2000). 7. Schlaepfer, D.D., and Hunter, T., Evidence for in vivo phosphorylation of the Grb2 SH2
Product Information Sheet - SE120017
. Gynecol. Survey, 45, 570-577 (1990). 10. Diez, M. et al., Evaluation of serum CA125 as a tumor marker in non-small cell lung cancer. Cancer, 67, 150-154 (1991). 11. Niloff, J.M. et al., Elevation
Data Sheet - IMMH1
techniques: A comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577 (1981). 5. Robbins, S.L., et al., The liver, the biliary tract and the pancreas. In: Basic Pathology
Data Sheet - P8333
of PKC α (659-672), PKC β1 (658-671), PKC β2 (660-673), PKC γ(684-697), PKC ε (726-737), or PKC ξ (577-592). Anti-Protein Kinase C δ specifically reacts in dot-blot immunoassay with PKC δ peptide conjugated
Page 1 of 4